Tioga Cardiovascular, a portfolio company of Shifamed LLC, was founded with the mission to revolutionize valve replacement solutions for mitral and tricuspid applications. The company focuses on developing next-generation, less invasive transcatheter approaches that simplify procedures and improve patient outcomes. Their innovative products aim to address the complexities of traditional valve replacement surgeries, making them more accessible and less risky for patients.

Notable investors in Tioga Cardiovascular include Shifamed LLC, which has supported the company through multiple financing rounds, including Series A, B, and C, totaling $75 million. The company has achieved significant milestones, such as closing substantial funding rounds and advancing their product development pipeline. Tioga Cardiovascular's impact lies in its potential to transform cardiac care by offering safer and more efficient valve replacement options.